This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Codexis Awarded Biofuels Enzyme Patent

Codexis, Inc. (Nasdaq:CDXS), a developer of industrial enzymes to enable the production of biofuels, biobased chemicals, and pharmaceutical intermediates, today announced it has been awarded a key patent from the U.S. Patent and Trademark Office covering an important component of the company’s proprietary enzymatic technology that can be used for production of cellulosic biofuels.

Codexis specifically received U.S. Patent No. 8,143,050, “Recombinant Beta-Glucosidase Variants for Production of Soluble Sugars from Cellulosic Biomass”.

“This patent covers an enzyme group essential in the conversion of cellulosic biomass to fermentable sugars, which can subsequently be used for the production of a wide range of cellulosic biofuels,” said Peter Strumph, Interim Chief Executive Officer. “This adds to the strong Codexis intellectual property portfolio already in place and further strengthens the competitive position in the biofuels market for both Codexis and Shell, our advanced biofuels development partner.”

This is the latest patent to be added to the company’s portfolio of intellectual property which also includes patents covering the company’s CodeXyme™ Cellulase Enzymes and CodeEvolver™ directed evolution technology platform, among others.

About Codexis, Inc.

Codexis, Inc. is a developer of industrial enzymes to enable the production of biofuels, biobased chemicals and pharmaceutical intermediates. Codexis’ product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see www.codexis.com.

Forward-Looking Statements

This press release contains forward-looking statements relating to the Codexis intellectual property portfolio and the patent on biofuels technology referred to in this press release. Important factors that could cause actual results to differ materially from the forward-looking statements in this press release include risks that we may not be able to enforce our intellectual property rights and that we may not be able to compete if we lose some of our intellectual property rights. Additional factors that could materially affect actual results can be found in Codexis’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 5, 2012, including under the caption “Risk Factors.” Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs